Cargando…
The NISTmAb Reference Material 8671 lifecycle management and quality plan
Comprehensive analysis of monoclonal antibody therapeutics involves an ever expanding cadre of technologies. Lifecycle-appropriate application of current and emerging techniques requires rigorous testing followed by discussion between industry and regulators in a pre-competitive space, an effort tha...
Autores principales: | Schiel, John E., Turner, Abigail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830479/ https://www.ncbi.nlm.nih.gov/pubmed/29430600 http://dx.doi.org/10.1007/s00216-017-0844-2 |
Ejemplares similares
-
The NISTmAb Reference Material 8671 value assignment, homogeneity, and stability
por: Schiel, John E., et al.
Publicado: (2018) -
Qualification of NISTmAb charge heterogeneity control assays
por: Turner, Abigail, et al.
Publicado: (2018) -
Development of orthogonal NISTmAb size heterogeneity control methods
por: Turner, Abigail, et al.
Publicado: (2018) -
Heterologous recombinant expression of non-originator NISTmAb
por: Kashi, Lila, et al.
Publicado: (2018) -
Development of an LC-MS/MS peptide mapping protocol for the NISTmAb
por: Mouchahoir, Trina, et al.
Publicado: (2018)